These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 8871601

  • 1. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice.
    Apelgren LD, Bailey DL, Fouts RL, Short L, Bryan N, Evans GF, Sandusky GE, Zuckerman SH, Glasebrook A, Bumol TF.
    Cell Immunol; 1996 Oct 10; 173(1):55-63. PubMed ID: 8871601
    [Abstract] [Full Text] [Related]

  • 2. Effects of raloxifene, a selective estrogen receptor modulator, on thymus, T cell reactivity, and inflammation in mice.
    Erlandsson MC, Gömöri E, Taube M, Carlsten H.
    Cell Immunol; 2000 Nov 01; 205(2):103-9. PubMed ID: 11104582
    [Abstract] [Full Text] [Related]

  • 3. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 01; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 4. The ethyl acetate extract of alfalfa sprout ameliorates disease severity of autoimmune-prone MRL-lpr/lpr mice.
    Hong YH, Huang CJ, Wang SC, Lin BF.
    Lupus; 2009 Mar 01; 18(3):206-15. PubMed ID: 19213858
    [Abstract] [Full Text] [Related]

  • 5. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec 01; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

  • 6. Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus.
    Gutierrez-Ramos JC, Andreu JL, Revilla Y, Viñuela E, Martinez C.
    Nature; 1990 Jul 19; 346(6281):271-4. PubMed ID: 1973822
    [Abstract] [Full Text] [Related]

  • 7. Characterization of intermediate T-cell receptor cells expanding in the liver, thymus and other organs in autoimmune lpr mice: parallel analysis with their normal counterparts.
    Iiai T, Kimura M, Kawachi Y, Hirokawa K, Watanabe H, Hatakeyama K, Abo T.
    Immunology; 1995 Apr 19; 84(4):601-8. PubMed ID: 7790034
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.
    Wenderfer SE, Ke B, Hollmann TJ, Wetsel RA, Lan HY, Braun MC.
    J Am Soc Nephrol; 2005 Dec 19; 16(12):3572-82. PubMed ID: 16207826
    [Abstract] [Full Text] [Related]

  • 10. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K, Nakamura A, Sugahara A, Takai T.
    Eur J Immunol; 2003 Apr 19; 33(4):1020-9. PubMed ID: 12672068
    [Abstract] [Full Text] [Related]

  • 11. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA, Lee B, Burek CL, Saboori AM, Prendergast RA.
    Invest Ophthalmol Vis Sci; 1996 Feb 19; 37(2):377-83. PubMed ID: 8603842
    [Abstract] [Full Text] [Related]

  • 12. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L, Weinreb A, Wang XP, Zack DJ, Qiao JH, Weisbart R, Lusis AJ.
    J Immunol; 1998 Dec 15; 161(12):6999-7006. PubMed ID: 9862736
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA, Burns WH, Prendergast RA.
    Invest Ophthalmol Vis Sci; 1996 Jan 15; 37(1):246-50. PubMed ID: 8550330
    [Abstract] [Full Text] [Related]

  • 15. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 16. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
    J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217
    [Abstract] [Full Text] [Related]

  • 17. Lack of association of V beta 8+ T cells with lupus-like syndrome in MRL-lpr/lpr mice.
    Fossati L, Merino R, Iwamoto M, Lemoine R, Izui S.
    Eur J Immunol; 1994 Jul 01; 24(7):1717-20. PubMed ID: 8026533
    [Abstract] [Full Text] [Related]

  • 18. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F, Tsukimoto M, Nakatsukasa H, Kojima S.
    Radiat Res; 2008 Jan 01; 169(1):59-66. PubMed ID: 18159952
    [Abstract] [Full Text] [Related]

  • 19. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B, Gee RJ, Kashgarian MJ, Sharpe AH, Mamula MJ.
    J Immunol; 1999 Aug 15; 163(4):2322-9. PubMed ID: 10438978
    [Abstract] [Full Text] [Related]

  • 20. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.
    Chan O, Shlomchik MJ.
    J Immunol; 1998 Jan 01; 160(1):51-9. PubMed ID: 9551955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.